Ipratropium Bromide Nebuamp and Moxetumomab pasudotox
Determining the interaction of Ipratropium Bromide Nebuamp and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation, Ipratropium (Oral Inhalation)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ipratropium Bromide Nebuamp-Moxetumomab Pasudotox-tdfk
- Ipratropium Bromide Nebuamp-Moxetumomab pasudotox-tdfk Intravenous
- Ipratropium Bromide Nebuamp-Moxifloxacin
- Ipratropium Bromide Nebuamp-Moxifloxacin (Systemic)
- Ipratropium Bromide Nebuamp-Moxifloxacin Hydrochloride
- Ipratropium Bromide Nebuamp-Moxifloxacin Injection
- Moxetumomab pasudotox-Ipratropium inhalation
- Moxetumomab pasudotox-Ipratropium Inhalation Aerosol
- Moxetumomab pasudotox-Ipratropium Inhalation Solution
- Moxetumomab pasudotox-Ipratropium Inhalation, oral/nebulization
- Moxetumomab pasudotox-Ipratropium nasal
- Moxetumomab pasudotox-Ipratropium Nasal 0.03